Protecting The Pharmaceutical Industry Against Illicit Trade And Falsified Medicines

With sales of falsified, substandard and counterfeit pharmaceuticals estimated at around $200 billion annually, the illicit pharmaceutical market tops the luxury goods, alcohol and even tobacco industry’s illicit sales as the most lucrative imitation market. Such a profitable market continues to attract specialist counterfeiters and organised crime, making it clear that challenge of illicit pharmaceuticals is only growing despite public and private efforts.

The FMD is here and companies trading in the European market have serialised – so what’s next in the fight against fakes? Can you say that your supply chain is now secure and your regional market presence risk free? If so, you are now in a unique industry position. If not – don’t worry, that is why we are bringing the industries leading supply chain, brand protection and anti-counterfeiting experts together in Zurich this June.

We know that there is no single way for brands to prevent the illegal copying of their products, and that global regulations, such as the FMD and DSCSA, are only one step in the right direction. With a focus on understanding the scope and weaknesses in your current brand protection strategy, and pinpointing the best opportunities for greater supply chain securitisation, this year’s forum is designed to give you the tools and connections to move past FMD compliance and into proactive brand and supply chain protection.

Held In Association With:

Transnational Alliance to Combat Illicit Trade

Association for Safe Online Pharmacies (ASOP)

Meet Our Speakers

Meet Our Speakers

Join Discussions With Industry Experts On: 


Security beyond serialisation: Understanding how FMD implementation can add value to your brand protection efforts beyond serialisation


Optimisation of your supply chain visibility: Establishing a holistic risk profile and pinpointing your weaknesses to develop targeted mitigation strategies


Balancing brand exposure and external partner selection in emerging markets to minimise the presence of counterfeit materials


Utilising serialisation as a business asset beyond traceability: Understanding how to spot counterfeits in your supply chain 


Creating a 360 degree anti-counterfeiting approach: Overt and covert technology applications for effective counterfeit mitigation 

Sponsors & Exhibitors
Media Partners